Ke Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ke Lin has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Weiqiang Ruan
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, People’s Republic of China
12 shared publicationsGuiying Zhang
Research Center of Clinical Epidemiology and Evidence-Based Medicine, West China Hospital, Sichuan University, Chengdu, People’s Republic of China
4 shared publicationsHuizhen Liu
Center of Biostatistics, Design, Measurement and Evaluation (CBDME), Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu, People’s Republic of China
4 shared publicationsLin Xie
Sichuan University
4 shared publicationsTing Wang
Center of Biostatistics, Design, Measurement and Evaluation (CBDME), Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu, People’s Republic of China
4 shared publicationsXiaoqin Zhou
Department of Vascular Surgery, West China Hospital, Sichuan University, Chengdu, People’s Republic of China
4 shared publications
Latest Publications
- Open Access
- 9 January 2025
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 20 (1) , 92
Global Trends in Ischemic Heart Disease Mortality from 1990 to 2021 and 2036 Projections: Insights from GBD 2021 Data
Background: Ischemic heart disease (IHD) remains a significant global health challenge despite advancements in prevention and treatment. This study aims to comprehensively analyze global IHD mortality trends from 1990 to 2021 and projections for 2036, to support evidence-based decision-making for IHD prevention and management strategies across diverse contexts. Methods: Using data from the Global Burden of Disease Study 2021, we conducted multi-level analyses of IHD mortality trends: globally, across socio-demographic index (SDI) quintiles, 21 Global Burden of Disease (GBD) regions, and 204 countries. We performed age-period-cohort (APC), decomposition, risk factor, and frontier analysis. Bayesian APC modeling was used for projections to 2036. Results: The global age-standardized mortality rate (ASMR) for IHD decreased from 1990 to 2021 (EAPC: –1.301%, net drift: –1.1%) despite a 67.5% increase in total deaths. APC analysis revealed exponential growth in IHD mortality rates with age, with the inflection point at 62.5 years in low SDI regions and 77.5 years in high SDI regions. High SDI regions demonstrated significant period and cohort effects. Frontier analysis showed that Nauru and Ukraine were the countries with the highest effective differences. Decomposition analysis identified population growth and aging as primary factors increasing IHD mortality. High systolic blood pressure remained the leading global risk factor, with increasing contributions from high fasting plasma glucose and high body-mass index, especially in high SDI regions. Projections indicate continued global ASMR decrease by 2036, but with concerning increases in Eastern Europe and some African regions. Conclusions: This study reveals the complex global landscape of IHD, emphasizing that high SDI regions should focus on comprehensive care for older adults and managing metabolic risk factors such as diabetes and obesity, while low and middle SDI regions need to strengthen healthcare systems and implement early prevention strategies. Regions projecting mortality increases require urgent attention and interventions. HIGHLIGHTS What is new? Global IHD age-standardized mortality rates decreased from 1990 to 2021 (EAPC: –1.301%, net drift: –1.1%), despite a 67.5% increase in total deaths, reflecting advancements in care and ongoing challenges of population aging and growth. APC analysis showed exponential growth in IHD mortality rates with age across all SDI regions, with low SDI regions’ inflection point 15 years earlier than high SDI regions, suggesting prioritization of comprehensive care for the elderly in high SDI areas. Decomposition analysis showed South Asia and East Asia experienced the largest increases in IHD deaths, with epidemiological changes contributing to death increases rather than reductions, underscoring the need for effective policies to address population growth and aging in these rapidly developing regions. High systolic blood pressure remains the leading global risk factor for IHD, with increasing contributions from high fasting plasma glucose and high body-mass index, especially in high SDI regions. Projections indicate continued global ASMR decrease by 2036, but with concerning increases in Eastern Europe and some African regions, particularly Southern Sub-Saharan Africa, necessitating targeted interventions. What are the clinical implications? High SDI regions should focus on comprehensive care for the elderly and managing metabolic risks like hypertension, diabetes, and obesity. Low and middle SDI regions need to strengthen healthcare systems and implement early prevention to combat rising IHD mortality. Regions with projected increases, such as Eastern Europe and Southern Sub-Saharan Africa, require urgent policy interventions and resource allocation to address disparities and improve preventive care access.
- 9 January 2025
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 20 (1) , 92
Open AccessGlobal Trends in Ischemic Heart Disease Mortality from 1990 to 2021 and 2036 Projections: Insights from GBD 2021 Data
Background: Ischemic heart disease (IHD) remains a significant global health challenge despite advancements in prevention and treatment. This study aims to comprehensively analyze global IHD mortality trends from 1990 to 2021 and projections for 2036, to support evidence-based decision-making for IHD prevention and management strategies across diverse contexts. Methods: Using data from the Global Burden of Disease Study 2021, we conducted multi-level analyses of IHD mortality trends: globally, across socio-demographic index (SDI) quintiles, 21 Global Burden of Disease (GBD) regions, and 204 countries. We performed age-period-cohort (APC), decomposition, risk factor, and frontier analysis. Bayesian APC modeling was used for projections to 2036. Results: The global age-standardized mortality rate (ASMR) for IHD decreased from 1990 to 2021 (EAPC: –1.301%, net drift: –1.1%) despite a 67.5% increase in total deaths. APC analysis revealed exponential growth in IHD mortality rates with age, with the inflection point at 62.5 years in low SDI regions and 77.5 years in high SDI regions. High SDI regions demonstrated significant period and cohort effects. Frontier analysis showed that Nauru and Ukraine were the countries with the highest effective differences. Decomposition analysis identified population growth and aging as primary factors increasing IHD mortality. High systolic blood pressure remained the leading global risk factor, with increasing contributions from high fasting plasma glucose and high body-mass index, especially in high SDI regions. Projections indicate continued global ASMR decrease by 2036, but with concerning increases in Eastern Europe and some African regions. Conclusions: This study reveals the complex global landscape of IHD, emphasizing that high SDI regions should focus on comprehensive care for older adults and managing metabolic risk factors such as diabetes and obesity, while low and middle SDI regions need to strengthen healthcare systems and implement early prevention strategies. Regions projecting mortality increases require urgent attention and interventions. HIGHLIGHTS What is new? Global IHD age-standardized mortality rates decreased from 1990 to 2021 (EAPC: –1.301%, net drift: –1.1%), despite a 67.5% increase in total deaths, reflecting advancements in care and ongoing challenges of population aging and growth. APC analysis showed exponential growth in IHD mortality rates with age across all SDI regions, with low SDI regions’ inflection point 15 years earlier than high SDI regions, suggesting prioritization of comprehensive care for the elderly in high SDI areas. Decomposition analysis showed South Asia and East Asia experienced the largest increases in IHD deaths, with epidemiological changes contributing to death increases rather than reductions, underscoring the need for effective policies to address population growth and aging in these rapidly developing regions. High systolic blood pressure remains the leading global risk factor for IHD, with increasing contributions from high fasting plasma glucose and high body-mass index, especially in high SDI regions. Projections indicate continued global ASMR decrease by 2036, but with concerning increases in Eastern Europe and some African regions, particularly Southern Sub-Saharan Africa, necessitating targeted interventions. What are the clinical implications? High SDI regions should focus on comprehensive care for the elderly and managing metabolic risks like hypertension, diabetes, and obesity. Low and middle SDI regions need to strengthen healthcare systems and implement early prevention to combat rising IHD mortality. Regions with projected increases, such as Eastern Europe and Southern Sub-Saharan Africa, require urgent policy interventions and resource allocation to address disparities and improve preventive care access.
- Open Access
- 20 July 2024
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 19 (1) , 1-6
Feasibility of epicardial implantation of medtronic 3830 lead in a pediatric patient : case report
Background: High-grade atrioventricular block is the primary reason for epicardial permanent pacemaker implantation during the perioperative period in patients with congenital heart disease. Due to the smaller diameter of venous vessels in children, epicardial permanent pacemaker implantation is usually a preferred choice, we report one pediatric patient who received epicardial permanent pacemaker implantation using a new approach. Case presentation: We present the case of a 2-year-old girl who underwent the modified Konno procedure and Pulmonary valvuloplasty surgery and presented after surgery with a High-grade atrioventricular block. At over 20 days after the patient underwent a redo-sternotomy which epicardial permanent pacemaker implantation. Medtronic Model 4965 Capsure Epi ® steroid-eluting unipolar epicardial pacing lead was immobilized on the surface of the right ear. The Medtronic 3830 pacing lead was screwed obliquely and clockwise under direct view from the surface of the right ventricle to the endocardium near the interventricular septum. The patient’s recovery was uneventful. Conclusion: In this case report, we demonstrate the feasibility and potential benefits of using the Medtronic 3830 lead for epicardial pacing in a pediatric patient with severe cardiac complications following surgery for congenital heart disease. This approach offers a viable alternative to traditional epicardial pacing methods, particularly in complex cases where conventional leads fail to provide stable pacing thresholds.
- 20 July 2024
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 19 (1) , 1-6
Open AccessFeasibility of epicardial implantation of medtronic 3830 lead in a pediatric patient : case report
Background: High-grade atrioventricular block is the primary reason for epicardial permanent pacemaker implantation during the perioperative period in patients with congenital heart disease. Due to the smaller diameter of venous vessels in children, epicardial permanent pacemaker implantation is usually a preferred choice, we report one pediatric patient who received epicardial permanent pacemaker implantation using a new approach. Case presentation: We present the case of a 2-year-old girl who underwent the modified Konno procedure and Pulmonary valvuloplasty surgery and presented after surgery with a High-grade atrioventricular block. At over 20 days after the patient underwent a redo-sternotomy which epicardial permanent pacemaker implantation. Medtronic Model 4965 Capsure Epi ® steroid-eluting unipolar epicardial pacing lead was immobilized on the surface of the right ear. The Medtronic 3830 pacing lead was screwed obliquely and clockwise under direct view from the surface of the right ventricle to the endocardium near the interventricular septum. The patient’s recovery was uneventful. Conclusion: In this case report, we demonstrate the feasibility and potential benefits of using the Medtronic 3830 lead for epicardial pacing in a pediatric patient with severe cardiac complications following surgery for congenital heart disease. This approach offers a viable alternative to traditional epicardial pacing methods, particularly in complex cases where conventional leads fail to provide stable pacing thresholds.
- Open Access
- 14 June 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Assessing the causal relationship between circulating immune cells and abdominal aortic aneurysm by bi-directional Mendelian randomization analysis
Although there is an association between abdominal aortic aneurysm (AAA) and circulating immune cell phenotypes, the exact causal relationship remains unclear. This study aimed to explore the causal relationships between immune cell phenotypes and AAA risk using a bidirectional two-sample Mendelian randomization approach. Data from genome-wide association studies pertaining to 731 immune cell traits and AAA were systematically analyzed. Using strict selection criteria, we identified 339 immune traits that are associated with at least 3 single nucleotide polymorphisms. A comprehensive MR analysis was conducted using several methods including Inverse Variance Weighted, Weighted Median Estimator, MR-Egger regression, Weighted Mode, and Simple Median methods. CD24 on switched memory cells (OR = 0.922, 95% CI 0.914–0.929, P = 2.62e−79) at the median fluorescence intensities level, and SSC-A on HLA-DR + natural killer cells (OR = 0.873, 95% CI 0.861–0.885, P = 8.96e−81) at the morphological parameter level, exhibited the strongest causal associations with AAA. In the reverse analysis, no significant causal effects of AAA on immune traits were found. The study elucidates the causal involvement of multiple circulating immune cell phenotypes in AAA development, signifying their potential as diagnostic markers or therapeutic targets. These identified immune traits may be crucial in modulating AAA-related inflammatory pathways.
- 14 June 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Open AccessAssessing the causal relationship between circulating immune cells and abdominal aortic aneurysm by bi-directional Mendelian randomization analysis
Although there is an association between abdominal aortic aneurysm (AAA) and circulating immune cell phenotypes, the exact causal relationship remains unclear. This study aimed to explore the causal relationships between immune cell phenotypes and AAA risk using a bidirectional two-sample Mendelian randomization approach. Data from genome-wide association studies pertaining to 731 immune cell traits and AAA were systematically analyzed. Using strict selection criteria, we identified 339 immune traits that are associated with at least 3 single nucleotide polymorphisms. A comprehensive MR analysis was conducted using several methods including Inverse Variance Weighted, Weighted Median Estimator, MR-Egger regression, Weighted Mode, and Simple Median methods. CD24 on switched memory cells (OR = 0.922, 95% CI 0.914–0.929, P = 2.62e−79) at the median fluorescence intensities level, and SSC-A on HLA-DR + natural killer cells (OR = 0.873, 95% CI 0.861–0.885, P = 8.96e−81) at the morphological parameter level, exhibited the strongest causal associations with AAA. In the reverse analysis, no significant causal effects of AAA on immune traits were found. The study elucidates the causal involvement of multiple circulating immune cell phenotypes in AAA development, signifying their potential as diagnostic markers or therapeutic targets. These identified immune traits may be crucial in modulating AAA-related inflammatory pathways.
- Open Access
- 12 June 2024
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 11 (5) , 3105-3119
Type 2 Diabetes Mellitus and Cardiovascular Health: Evidence of Causal Relationships in a European Ancestry Population
Aims: Type 2 diabetes mellitus (T2DM) is associated with increased cardiovascular disease (CVD) risk, but whether T2DM directly causes adverse cardiac remodelling is uncertain. We performed a comprehensive Mendelian randomization (MR) analysis to investigate the causal relevance of T2DM to CVD outcomes and cardiac structure/function. Methods and results: Bidirectional two-sample MR was conducted using summary-level data from European-ancestry genome-wide association studies. The T2DM GWAS data included 80 154 cases and 853 816 controls from the DIAGRAM consortium. Outcomes included coronary artery disease (CAD), myocardial infarction (MI), stroke, heart failure, atrial fibrillation, and various quantitative cardiac imaging traits assessed by magnetic resonance imaging. MR analysis revealed causal associations between genetic predisposition to T2DM and increased risk of CAD (odds ratio [OR] 1.104, 95% confidence interval [CI] 1.078–1.130, P = 2.59e-16), MI (OR 1.129, 95% CI 1.094–1.166, P = 6.02e-14) and stroke (OR 1.086, 95% CI 1.064–1.109, P = 1.02e-14). These associations were validated in the FinnGen cohort (CAD: OR 1.117, 95% CI 1.075–1.158, P = 1.56e-9; MI: OR 1.132, 95% CI 1.083–1.184, P = 4.27e-8; stroke: OR 1.138, 95% CI 1.107–1.170, P = 3.52e-20). Multivariable MR show consistent findings (CAD: OR 1.063, 95% CI 1.031–1.097, P = 1.11e-4; MI: OR 1.088, 95% CI 1.042–1.135, P = 1.12e-4; stroke: OR 1.066, 95% CI 1.032–1.101, P = 1.18e-4) after adjusting for cardiometabolic traits. T2DM was causally associated with higher left ventricular mass index (β = 0.473, 95% CI 0.193 to 0.752, P = 0.001), lower indexed right atrial minimum (β = −0.048, 95% CI −0.073 to −0.022, P = 2.1e-5), and maximum (β = −0.042, 95% CI −0.065 to −0.019, P = 4.12e-5) areas. The effects on right atrial size remained significant after adjusting for risk factors (minimum area: β = −0.041, 95% CI −0.072 to −0.010, P = 0.009; maximum area: β = −0.039, 95% CI −0.069 to −0.008, P = 0.012). Both apolipoprotein A1 and SBP are important mediators in the causal relationship between T2DM and left ventricular mass index. No reverse causal associations were identified. Conclusions: Our MR study demonstrates that genetic liability to T2DM plays causal roles in CAD, MI, stroke, and cardiac structure changes including left ventricular hypertrophy and reduced right atrial dimensions. These findings provide genetic evidence supporting glycaemic control in T2DM to mitigate cardiovascular complications and adverse cardiac remodelling.
- 12 June 2024
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 11 (5) , 3105-3119
Open AccessType 2 Diabetes Mellitus and Cardiovascular Health: Evidence of Causal Relationships in a European Ancestry Population
Aims: Type 2 diabetes mellitus (T2DM) is associated with increased cardiovascular disease (CVD) risk, but whether T2DM directly causes adverse cardiac remodelling is uncertain. We performed a comprehensive Mendelian randomization (MR) analysis to investigate the causal relevance of T2DM to CVD outcomes and cardiac structure/function. Methods and results: Bidirectional two-sample MR was conducted using summary-level data from European-ancestry genome-wide association studies. The T2DM GWAS data included 80 154 cases and 853 816 controls from the DIAGRAM consortium. Outcomes included coronary artery disease (CAD), myocardial infarction (MI), stroke, heart failure, atrial fibrillation, and various quantitative cardiac imaging traits assessed by magnetic resonance imaging. MR analysis revealed causal associations between genetic predisposition to T2DM and increased risk of CAD (odds ratio [OR] 1.104, 95% confidence interval [CI] 1.078–1.130, P = 2.59e-16), MI (OR 1.129, 95% CI 1.094–1.166, P = 6.02e-14) and stroke (OR 1.086, 95% CI 1.064–1.109, P = 1.02e-14). These associations were validated in the FinnGen cohort (CAD: OR 1.117, 95% CI 1.075–1.158, P = 1.56e-9; MI: OR 1.132, 95% CI 1.083–1.184, P = 4.27e-8; stroke: OR 1.138, 95% CI 1.107–1.170, P = 3.52e-20). Multivariable MR show consistent findings (CAD: OR 1.063, 95% CI 1.031–1.097, P = 1.11e-4; MI: OR 1.088, 95% CI 1.042–1.135, P = 1.12e-4; stroke: OR 1.066, 95% CI 1.032–1.101, P = 1.18e-4) after adjusting for cardiometabolic traits. T2DM was causally associated with higher left ventricular mass index (β = 0.473, 95% CI 0.193 to 0.752, P = 0.001), lower indexed right atrial minimum (β = −0.048, 95% CI −0.073 to −0.022, P = 2.1e-5), and maximum (β = −0.042, 95% CI −0.065 to −0.019, P = 4.12e-5) areas. The effects on right atrial size remained significant after adjusting for risk factors (minimum area: β = −0.041, 95% CI −0.072 to −0.010, P = 0.009; maximum area: β = −0.039, 95% CI −0.069 to −0.008, P = 0.012). Both apolipoprotein A1 and SBP are important mediators in the causal relationship between T2DM and left ventricular mass index. No reverse causal associations were identified. Conclusions: Our MR study demonstrates that genetic liability to T2DM plays causal roles in CAD, MI, stroke, and cardiac structure changes including left ventricular hypertrophy and reduced right atrial dimensions. These findings provide genetic evidence supporting glycaemic control in T2DM to mitigate cardiovascular complications and adverse cardiac remodelling.
- 13 May 2024
- Published by Elsevier in Heart Rhythm
- Vol. 21 (11) , 2272-2281
Thyroid function effect on cardiac structure, cardiac function, and disease risk: Evidence of causal associations in European ancestry
- 13 May 2024
- Published by Elsevier in Heart Rhythm
- Vol. 21 (11) , 2272-2281
Thyroid function effect on cardiac structure, cardiac function, and disease risk: Evidence of causal associations in European ancestry
- 7 May 2024
- Published by Elsevier in Heart & Lung
- Vol. 67, 70-79
Causal role of circulating inflammatory cytokines in cardiac diseases, structure and function
- 7 May 2024
- Published by Elsevier in Heart & Lung
- Vol. 67, 70-79
Causal role of circulating inflammatory cytokines in cardiac diseases, structure and function
- Open Access
- 23 March 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 47 (6) , 2731-2732
Identification of potential drug targets for abdominal aortic aneurysm through Mendelian randomization analysis
- 23 March 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 47 (6) , 2731-2732
Open AccessIdentification of potential drug targets for abdominal aortic aneurysm through Mendelian randomization analysis
- Open Access
- 8 January 2024
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 19 (1) , 83
Causal Links Between Renal Function and Cardiac Structure, Function, and Disease Risk
Background: Chronic kidney disease (CKD) increases the risk of adverse cardiovascular outcomes. However, the causal relationships between renal function and cardiovascular diseases (CVD) remain incompletely understood. This study aimed to determine the causal relationships between genetic susceptibility to impaired renal function and the risk of CVD endpoints, as well as cardiac structure and function detectable by cardiac magnetic resonance imaging (CMR). Methods: Bidirectional Mendelian randomization (MR) analyses were conducted using summary-level data from genome-wide association studies. The exposures were blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), urine albumin-to-creatinine ratio (UACR), and CKD. The outcomes included atrial fibrillation, coronary artery disease (CAD), myocardial infarction, heart failure, stroke, and various CMR parameters. Sensitivity analyses, multivariable MR adjusting for cardiometabolic traits, and replication in the FinnGen cohort were performed. Results: Elevated BUN levels (OR 1.505; 95% CI 1.077 to 2.103; P = 0.017) were causally associated with increased CAD risk, but this relationship was attenuated after adjusting for cardiometabolic traits. Increased UACR was causally linked to higher risks of CAD (OR 1.260; 95% CI 1.042 to 1.523; P = 0.017), myocardial infarction (OR 1.424; 95% CI 1.137 to 1.783; P = 0.002), and stroke (OR 1.182; 95% CI 1.012 to 1.379; P = 0.035), with the association for stroke remaining significant after multivariable adjustment. Reduced eGFR was causally related to decreases in ascending aorta diameter, proximal pulmonary artery diameter, right atrial size, left ventricular stroke volume, and right ventricular volumes, even after accounting for potential confounders. CKD was causally associated with a reduced pulmonary artery-to-aorta ratio and proximal pulmonary artery diameter. Conclusions: This comprehensive MR study establishes causal roles of genetic susceptibility to impaired renal function influencing cardiovascular outcomes and cardiac structure.
- 8 January 2024
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 19 (1) , 83
Open AccessCausal Links Between Renal Function and Cardiac Structure, Function, and Disease Risk
Background: Chronic kidney disease (CKD) increases the risk of adverse cardiovascular outcomes. However, the causal relationships between renal function and cardiovascular diseases (CVD) remain incompletely understood. This study aimed to determine the causal relationships between genetic susceptibility to impaired renal function and the risk of CVD endpoints, as well as cardiac structure and function detectable by cardiac magnetic resonance imaging (CMR). Methods: Bidirectional Mendelian randomization (MR) analyses were conducted using summary-level data from genome-wide association studies. The exposures were blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), urine albumin-to-creatinine ratio (UACR), and CKD. The outcomes included atrial fibrillation, coronary artery disease (CAD), myocardial infarction, heart failure, stroke, and various CMR parameters. Sensitivity analyses, multivariable MR adjusting for cardiometabolic traits, and replication in the FinnGen cohort were performed. Results: Elevated BUN levels (OR 1.505; 95% CI 1.077 to 2.103; P = 0.017) were causally associated with increased CAD risk, but this relationship was attenuated after adjusting for cardiometabolic traits. Increased UACR was causally linked to higher risks of CAD (OR 1.260; 95% CI 1.042 to 1.523; P = 0.017), myocardial infarction (OR 1.424; 95% CI 1.137 to 1.783; P = 0.002), and stroke (OR 1.182; 95% CI 1.012 to 1.379; P = 0.035), with the association for stroke remaining significant after multivariable adjustment. Reduced eGFR was causally related to decreases in ascending aorta diameter, proximal pulmonary artery diameter, right atrial size, left ventricular stroke volume, and right ventricular volumes, even after accounting for potential confounders. CKD was causally associated with a reduced pulmonary artery-to-aorta ratio and proximal pulmonary artery diameter. Conclusions: This comprehensive MR study establishes causal roles of genetic susceptibility to impaired renal function influencing cardiovascular outcomes and cardiac structure.
- Open Access
- 3 January 2024
- Published by Springer Nature in Research Square
A new approach for epicardial permanent pacemaker implantation in children: case report
Background High-grade atrioventricular block is the primary reason for epicardial permanent pacemaker implantation during the perioperative period in patients with congenital heart disease. Due to the smaller diameter of venous vessels in children, epicardial permanent pacemaker implantation is usually a preferred choice, we report one pediatric patient who received epicardial permanent pacemaker implantation using a new approach. Case presentation We present the case of a 2-year-old girl who underwent the modified Konno procedure and Pulmonary valvuloplasty surgery and presented after surgery with a High-grade atrioventricular block. At over 20 days after the patient underwent a redo-sternotomy which epicardial permanent pacemaker implantation. Medtronic Model 4965 Capsure Epi ® steroid-eluting unipolar epicardial pacing lead was immobilized on the surface of the right ear. The Medtronic 3830 pacing lead was screwed obliquely and clockwise under direct view from the surface of the right ventricle to the endocardium near the interventricular septum. The patient’s recovery was uneventful. Conclusion A Medtronic 3830 pacing lead was screwed into the myocardium through the epicardium, which is a feasible approach for implanting the ventricular pacing electrode.
- 3 January 2024
- Published by Springer Nature in Research Square
Open AccessA new approach for epicardial permanent pacemaker implantation in children: case report
Background High-grade atrioventricular block is the primary reason for epicardial permanent pacemaker implantation during the perioperative period in patients with congenital heart disease. Due to the smaller diameter of venous vessels in children, epicardial permanent pacemaker implantation is usually a preferred choice, we report one pediatric patient who received epicardial permanent pacemaker implantation using a new approach. Case presentation We present the case of a 2-year-old girl who underwent the modified Konno procedure and Pulmonary valvuloplasty surgery and presented after surgery with a High-grade atrioventricular block. At over 20 days after the patient underwent a redo-sternotomy which epicardial permanent pacemaker implantation. Medtronic Model 4965 Capsure Epi ® steroid-eluting unipolar epicardial pacing lead was immobilized on the surface of the right ear. The Medtronic 3830 pacing lead was screwed obliquely and clockwise under direct view from the surface of the right ventricle to the endocardium near the interventricular septum. The patient’s recovery was uneventful. Conclusion A Medtronic 3830 pacing lead was screwed into the myocardium through the epicardium, which is a feasible approach for implanting the ventricular pacing electrode.
- Open Access
- 12 September 2023
- Published by Springer Nature in Research Square
Three predictive models for transthoracic device closure of atrial septal defect: a comprehensive comparative analysis
Background: Atrial Septal Defect (ASD) is a common congenital heart disease. Although transthoracic occlusion of ASD is increasingly seen as a less invasive alternative to traditional surgery, the choice of procedure often relies on the surgeon's experience and the insights gained from transesophageal echocardiography (TEE) images, lacking concrete, quantifiable standards. This study aims to guide clinical surgical decisions by developing and comparing predictive models. Methods: We analyzed 312 patients with secundum atrial septal defects who underwent either transthoracic device closure or open surgical repair. By measuring and analyzing preoperative TEE data and utilizing statistical and programming software, we developed three predictive models: logistic regression, random forest, and multiple linear regression. The original data were divided into a training dataset and a testing dataset, with each model trained on the training dataset and validated on the testing dataset. The predictive performance of each model was then evaluated on both adult and pediatric data. Results: Each model exhibited remarkable predictive power. The prediction accuracies in the training dataset for the logistic regression model, random forest model, and multiple linear regression model were 0.892, 0.888, and 0.868, respectively. In the testing dataset, the prediction accuracies were 0.9194, 0.871, and 0.9194, respectively. Conclusions: This study developed three predictive models to guide clinical surgical decisions for ASD closure surgery. Among them, the multivariate linear regression model demonstrated significant predictive accuracy, offering the potential to streamline the clinical decision-making process. This model does not require complex computations and is capable of providing quick, real-time predictions.
- 12 September 2023
- Published by Springer Nature in Research Square
Open AccessThree predictive models for transthoracic device closure of atrial septal defect: a comprehensive comparative analysis
Background: Atrial Septal Defect (ASD) is a common congenital heart disease. Although transthoracic occlusion of ASD is increasingly seen as a less invasive alternative to traditional surgery, the choice of procedure often relies on the surgeon's experience and the insights gained from transesophageal echocardiography (TEE) images, lacking concrete, quantifiable standards. This study aims to guide clinical surgical decisions by developing and comparing predictive models. Methods: We analyzed 312 patients with secundum atrial septal defects who underwent either transthoracic device closure or open surgical repair. By measuring and analyzing preoperative TEE data and utilizing statistical and programming software, we developed three predictive models: logistic regression, random forest, and multiple linear regression. The original data were divided into a training dataset and a testing dataset, with each model trained on the training dataset and validated on the testing dataset. The predictive performance of each model was then evaluated on both adult and pediatric data. Results: Each model exhibited remarkable predictive power. The prediction accuracies in the training dataset for the logistic regression model, random forest model, and multiple linear regression model were 0.892, 0.888, and 0.868, respectively. In the testing dataset, the prediction accuracies were 0.9194, 0.871, and 0.9194, respectively. Conclusions: This study developed three predictive models to guide clinical surgical decisions for ASD closure surgery. Among them, the multivariate linear regression model demonstrated significant predictive accuracy, offering the potential to streamline the clinical decision-making process. This model does not require complex computations and is capable of providing quick, real-time predictions.